BioCentury
ARTICLE | Company News

Apexigen Inc., 3SBio deal

June 29, 2015 7:00 AM UTC

Apexigen granted 3SBio rights outside of China to SSS07. 3SBio already held rights in China to the humanized mAb that inhibits tumor necrosis factor (TNF) alpha under a 2006 deal. The companies decl...